Blocking AREG-EGFR signaling attenuates pan-arterial fibrosis in chronic cardiac allograft rejection

Pan-arterial fibrosis represents a unifying pathological process across major vascular territories in CAV. Targeting fibrotic remodeling may offer a promising adjunctive strategy to improve long-term graft outcomes.